Wall Street brokerages expect that Cardinal Health Inc (NYSE:CAH) will report earnings per share of $1.06 for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have provided estimates for Cardinal Health’s earnings. The highest EPS estimate is $1.10 and the lowest is $1.01. Cardinal Health reported earnings of $1.09 per share in the same quarter last year, which would indicate a negative year over year growth rate of 2.8%. The firm is scheduled to announce its next earnings report before the market opens on Thursday, November 8th.

According to Zacks, analysts expect that Cardinal Health will report full-year earnings of $5.02 per share for the current fiscal year, with EPS estimates ranging from $4.95 to $5.10. For the next year, analysts anticipate that the firm will post earnings of $5.41 per share, with EPS estimates ranging from $5.27 to $5.51. Zacks Investment Research’s earnings per share averages are an average based on a survey of analysts that cover Cardinal Health.

Cardinal Health (NYSE:CAH) last posted its earnings results on Monday, August 6th. The company reported $1.01 EPS for the quarter, beating the Zacks’ consensus estimate of $0.93 by $0.08. Cardinal Health had a net margin of 0.19% and a return on equity of 22.59%. The company had revenue of $35.35 billion for the quarter, compared to analysts’ expectations of $34.38 billion. During the same quarter in the prior year, the company posted $1.31 earnings per share. Cardinal Health’s revenue for the quarter was up 7.2% compared to the same quarter last year.

A number of research firms have commented on CAH. Royal Bank of Canada set a $60.00 target price on shares of Cardinal Health and gave the company a “hold” rating in a research report on Friday, September 21st. Zacks Investment Research cut shares of Cardinal Health from a “hold” rating to a “sell” rating in a research report on Tuesday, October 9th. Argus decreased their target price on shares of Cardinal Health from $85.00 to $75.00 and set a “buy” rating on the stock in a research report on Monday, July 16th. Robert W. Baird decreased their target price on shares of Cardinal Health from $51.00 to $50.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 7th. Finally, Morgan Stanley decreased their target price on shares of Cardinal Health from $55.00 to $40.00 and set an “underweight” rating on the stock in a research report on Tuesday, July 3rd. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $61.33.

In other Cardinal Health news, CEO Jon L. Giacomin sold 2,890 shares of the business’s stock in a transaction dated Monday, August 20th. The shares were sold at an average price of $51.95, for a total transaction of $150,135.50. Following the sale, the chief executive officer now directly owns 72,652 shares in the company, valued at $3,774,271.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.10% of the stock is owned by corporate insiders.

A number of large investors have recently modified their holdings of the business. World Asset Management Inc increased its stake in Cardinal Health by 4.2% during the third quarter. World Asset Management Inc now owns 26,721 shares of the company’s stock worth $1,443,000 after purchasing an additional 1,078 shares during the period. Sigma Planning Corp increased its stake in Cardinal Health by 17.0% during the second quarter. Sigma Planning Corp now owns 8,650 shares of the company’s stock worth $422,000 after purchasing an additional 1,256 shares during the period. Ladenburg Thalmann Financial Services Inc. increased its stake in shares of Cardinal Health by 7.2% during the first quarter. Ladenburg Thalmann Financial Services Inc. now owns 18,987 shares of the company’s stock worth $1,190,000 after buying an additional 1,272 shares during the period. Migdal Insurance & Financial Holdings Ltd. increased its stake in shares of Cardinal Health by 23.2% during the second quarter. Migdal Insurance & Financial Holdings Ltd. now owns 6,826 shares of the company’s stock worth $333,000 after buying an additional 1,287 shares during the period. Finally, Wrapmanager Inc. increased its stake in shares of Cardinal Health by 23.4% during the second quarter. Wrapmanager Inc. now owns 6,836 shares of the company’s stock worth $334,000 after buying an additional 1,297 shares during the period. Institutional investors own 90.56% of the company’s stock.

NYSE CAH traded down $0.23 during trading hours on Friday, reaching $53.19. The company had a trading volume of 3,004,379 shares, compared to its average volume of 3,300,918. Cardinal Health has a 1-year low of $48.14 and a 1-year high of $75.75. The company has a debt-to-equity ratio of 1.32, a current ratio of 1.07 and a quick ratio of 0.53. The stock has a market capitalization of $16.02 billion, a P/E ratio of 10.64, a PEG ratio of 1.69 and a beta of 1.02.

The firm also recently declared a quarterly dividend, which was paid on Monday, October 15th. Shareholders of record on Monday, October 1st were paid a dividend of $0.4763 per share. The ex-dividend date was Friday, September 28th. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.48. This represents a $1.91 dividend on an annualized basis and a yield of 3.58%. Cardinal Health’s dividend payout ratio is 38.20%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.

Featured Story: What is a Stop Order?

Get a free copy of the Zacks research report on Cardinal Health (CAH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.